These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35153267)

  • 1. [A case of SIADH due to pancreatic cancer was improved by tolvaptan].
    Matsuyama S; Ueo T; Ozawa T; Matsumoto A; Minami R; Kimura Y; Takeda Y; Okano A; Kusumi F; Ohana M
    Nihon Shokakibyo Gakkai Zasshi; 2022; 119(2):172-178. PubMed ID: 35153267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis.
    Humayun MA; Cranston IC
    BMC Endocr Disord; 2017 Nov; 17(1):69. PubMed ID: 29110656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
    Gralla RJ; Ahmad F; Blais JD; Chiodo J; Zhou W; Glaser LA; Czerwiec FS
    Cancer Med; 2017 Apr; 6(4):723-729. PubMed ID: 28251822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapsing Syndrome of Inappropriate Antidiuretic Hormone Production Responding to Tolvaptan Treatment in a Patient With a Micronodular Formation of the Posterior Pituitary Gland.
    Reinke LM; Seoudy AK; Gärtner F; Rohmann N; Schulte DM; Schreiber S; Jansen O; Laudes M
    Exp Clin Endocrinol Diabetes; 2023 Sep; 131(9):472-475. PubMed ID: 37364592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.
    Jamookeeah C; Robinson P; O'Reilly K; Lundberg J; Gisby M; Ländin M; Skov J; Trueman D
    BMC Endocr Disord; 2016 May; 16(1):22. PubMed ID: 27184496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan.
    De Las Peñas R; Ponce S; Henao F; Camps Herrero C; Carcereny E; Escobar Álvarez Y; Rodríguez CA; Virizuela JA; López López R
    Support Care Cancer; 2016 Jan; 24(1):499-507. PubMed ID: 26431960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid levels with tolvaptan treatment for syndrome of inappropriate antidiuretic hormone secretion.
    Nagamine T
    Endocrine; 2024 Mar; 83(3):826-827. PubMed ID: 37982946
    [No Abstract]   [Full Text] [Related]  

  • 8. Tolvaptan is successful in treating inappropriate antidiuretic hormone secretion in infants.
    Marx-Berger D; Milford DV; Bandhakavi M; Van't Hoff W; Kleta R; Dattani M; Bockenhauer D
    Acta Paediatr; 2016 Jul; 105(7):e334-7. PubMed ID: 27028950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolvaptan for SIADH in Myelodysplastic Syndrome with Blast Crisis.
    Mali P; Muduganti SR; Mujibur R; Murali N
    WMJ; 2015 Apr; 114(2):66-8. PubMed ID: 26756059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tolvaptan on hyponatremia in a dog with syndrome of inappropriate secretion of antidiuretic hormone.
    Yamamoto H; Kimura K; Horikirizono H; Tamura Y; Kambayashi S; Baba K; Okuda M; Mizuno T; Igase M
    J Vet Med Sci; 2023 Oct; 85(10):1047-1051. PubMed ID: 37587049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: Secondary failure to tolvaptan in a patient with SCLC and paraneoplastic SIADH.
    Menzi S; Jaramillo SD; Pfister S; Schefer H; Jehle AW
    Front Endocrinol (Lausanne); 2024; 15():1382066. PubMed ID: 38803472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan.
    Petereit C; Zaba O; Teber I; Lüders H; Grohé C
    BMC Pulm Med; 2013 Aug; 13():55. PubMed ID: 23987478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolvaptan corrects hyponatremia and relieves the burden of fluid/dietary restriction and hospitalization in hyponatremic patients with terminal lung cancer: a report of two cases.
    Kai K; Tominaga N; Koitabashi K; Ichikawa D; Shibagaki Y
    CEN Case Rep; 2019 May; 8(2):112-118. PubMed ID: 30637666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study.
    Estilo A; McCormick L; Rahman M
    Adv Ther; 2021 Dec; 38(12):5721-5736. PubMed ID: 34693505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH.
    Bordi P; Tiseo M; Buti S; Regolisti G; Ardizzoni A
    Tumori; 2015 Apr; 101(2):e51-3. PubMed ID: 25702667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolvaptan for Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in a Child with Corpus Callosum Agenesis.
    Meena AK; Nanda PM; Sharma R; Chakrabarty B; Gulati S
    Indian J Pediatr; 2024 Feb; 91(2):188-190. PubMed ID: 36757652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prompt efficacy of tolvaptan in treating hyponatremia of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) closely associated with rupture of a gastric artery aneurysm.
    Yamashita T; Yoshida M; Yamada H; Asano T; Aoki A; Ikoma A; Kusaka I; Kakei M; Ishikawa SE
    Intern Med; 2014; 53(8):845-9. PubMed ID: 24739604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective study on tolvaptan prescription in clinical practice in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH) using the Japanese claims database.
    Hagiwara D; Matsukawa M; Tasaki J; Nakamura Y; Arima H
    Endocr J; 2023 Dec; 70(12):1195-1205. PubMed ID: 37914256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose tolvaptan for the treatment of hyponatremia in the syndrome of inappropriate ADH secretion (SIADH).
    Harbeck B; Lindner U; Haas CS
    Endocrine; 2016 Sep; 53(3):872-3. PubMed ID: 26961548
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of tolvaptan in a case of severe hyponatriemia in SIADH during meningitis].
    Rollino C; Balbiano R; Caramello P; Roccatello D
    G Ital Nefrol; 2013; 30(6):. PubMed ID: 24402662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.